These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26550686)

  • 1. Diagnosing hypogonadism and treating decisions in different parts of the world: shifts in patterns between 2006 and 2015.
    Gooren L
    Aging Male; 2016; 19(1):46-53. PubMed ID: 26550686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research.
    Gooren LJ; Behre HM; Saad F; Frank A; Schwerdt S
    Aging Male; 2007 Dec; 10(4):173-81. PubMed ID: 18033626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010.
    Gooren LJ; Behre HM
    Aging Male; 2012 Mar; 15(1):22-7. PubMed ID: 22284307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypogonadism is not being sufficiently recognised in 99% of general practices/family doctor surgeries.
    Stedman M; Livingston M; Albanese M; Hackett G; Heald AH
    Int J Clin Pract; 2020 Feb; 74(2):e13445. PubMed ID: 31713967
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease.
    Morden NE; Woloshin S; Brooks CG; Schwartz LM
    JAMA Intern Med; 2019 Mar; 179(3):446-448. PubMed ID: 30592484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of treating male hypogonadism on couples' sexual desire and function.
    Conaglen JV; Conaglen HM
    J Sex Med; 2009 Feb; 6(2):456-63. PubMed ID: 19215616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Testosterone Prescription and Public Health Concerns.
    Gabrielsen JS; Najari BB; Alukal JP; Eisenberg ML
    Urol Clin North Am; 2016 May; 43(2):261-71. PubMed ID: 27132584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members.
    Yafi FA; Haney NM; Anaissie J; DeLay KJ; Trost L; Khera M; Hellstrom WJG
    Urology; 2017 Aug; 106():87-95. PubMed ID: 28479477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in testosterone therapy for men.
    Corona G; Rastrelli G; Forti G; Maggi M
    J Sex Med; 2011 Mar; 8(3):639-54; quiz 655. PubMed ID: 21711483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment patterns of testosterone replacement medications.
    Donatucci C; Cui Z; Fang Y; Muram D
    J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of hypogonadism in men.
    Bhasin S; Basaria S
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):251-70. PubMed ID: 21397197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study.
    Mascarenhas A; Khan S; Sayal R; Knowles S; Gomes T; Moore JE
    Aging Male; 2016 Jun; 19(2):90-5. PubMed ID: 26927629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Analysis of Dose Titration and Serum Testosterone Level Assessments in Patients Treated With Topical Testosterone.
    Muram D; Kaltenboeck A; Boytsov N; Hayes-Larson E; Ivanova J; Birnbaum HG; Swindle R
    Am J Mens Health; 2015 Nov; 9(6):496-505. PubMed ID: 25271142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
    Behre HM; Kliesch S; Leifke E; Link TM; Nieschlag E
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2386-90. PubMed ID: 9253305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary hypogonadism in men by the transdermal administration of testosterone.
    Findlay JC; Place V; Snyder PJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):369-73. PubMed ID: 2493029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratoristic strategy in late onset hypogonadism.
    Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
    Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.